Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jul;468(7):1991-6.
doi: 10.1007/s11999-009-1192-0. Epub 2009 Dec 18.

Case reports: subtrochanteric femoral stress fractures after prolonged alendronate therapy

Affiliations

Case reports: subtrochanteric femoral stress fractures after prolonged alendronate therapy

Katerina Cermak et al. Clin Orthop Relat Res. 2010 Jul.

Abstract

Background: Alendronate is known for its ability to reduce bone loss in osteoporotic and osseous metastatic conditions. Its long-term effects remain unclear although several reports describe cases of proximal femur stress fractures associated with long-term alendronate use.

Case description: We report the cases of four women who sustained low-energy subtrochanteric or femoral shaft stress fractures while being on alendronate therapy for more than 5 years. All radiographs showed typical patterns consisting of a transverse fracture line with external cortical bone reaction and medial cortical spike. Alendronate discontinuation along with nonoperative treatment was sufficient for one patient, whereas surgical stabilization was required in three patients.

Literature review: The side effects of alendronate therapy include osteonecrosis of the jaw, esophageal irritation, and musculoskeletal pain. Several cases of insufficiency femoral fractures associated with prolonged alendronate use have been reported. Their radiographic pattern and clinical presentation are consistent with our observations. Although various hypotheses have been suggested, the physiopathogenesis of these stress fractures is not completely understood.

Purposes and clinical relevance: Although bisphosphonates play an important role in preventing pathologic fractures in patients with cancer, these subtrochanteric stress fractures associated with prolonged use of alendronate should not be ignored.

PubMed Disclaimer

Figures

Fig. 1A–C
Fig. 1A–C
(A) An AP radiograph shows a nondisplaced incomplete fracture of the left femur with an (B) external cortical reaction. (C) An AP radiograph shows the femur after plate fixation of the fracture.
Fig. 2A–F
Fig. 2A–F
AP radiographs show (A) right and (B) left femoral shaft cortical reactions. (C) An AP radiograph shows a right femur transverse fracture with medial spike. (D) Right and (E) left AP radiographs show the femurs after intramedullary nailing. (F) Removal of the distal left locking screw led to subsequent healing.
Fig. 3A–E
Fig. 3A–E
(A) AP and (B) lateral radiographs show an external cortical shaft reaction without an evident fracture line. The cortical reaction is identified on a (C) MR image and (D) CT scan. (E) An AP radiograph taken 1 year after initial presentation shows a similar image despite clinical improvement.
Fig. 4A–B
Fig. 4A–B
(A) An AP radiograph shows a displaced transverse subtrochanteric fracture of the right femur with external cortex thickening and spiking of the medial cortex. (B) Another AP radiograph shows the right femur after intramedullary nailing of the fracture.
Fig. 5
Fig. 5
A diagram illustrates the distraction and compression areas in the proximal femoral shaft as suggested by Blaimont et al. [6].

References

    1. Abrahamsen B, Eiken P, Eastell R. Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study. J Bone Miner Res. 2009;24:1095–1102. doi: 10.1359/jbmr.081247. - DOI - PubMed
    1. Allen MR, Gineyts E, Leeming DJ, Burr DB, Delmas PD. Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra. Osteoporos Int. 2008;19:329–337. doi: 10.1007/s00198-007-0533-7. - DOI - PubMed
    1. Aspenberg P. Bisphosphonate-induced fractures: nature strikes back? Acta Orthop. 2008;79:459–460. doi: 10.1080/17453670710015427. - DOI - PubMed
    1. Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud KE. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet. 1996;348:1535–1541. doi: 10.1016/S0140-6736(96)07088-2. - DOI - PubMed
    1. Black DM, Schwartz AV, Ensrud KE, Cauley JA, Levis S, Quandt SA, Satterfield S, Wallace RB, Bauer DC, Palermo L, Wehren LE, Lombardi A, Santora AC, Cummings SR, FLEX Research Group Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA. 2006;296:2927–2938. doi: 10.1001/jama.296.24.2927. - DOI - PubMed

Publication types

MeSH terms

Substances